ArticleFrontiers in oncology2021

Discovery and Pharmacological Evaluation of STEAP4 as a Novel Target for HER2 Overexpressing Breast Cancer.

Ioanna-Maria Orfanou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.